Comparative Study of Rocuronium With Vecuronium (Study 71101)(COMPLETED)
Completed
Merck Sharp & Dohme Corp.
Phase 3
2003-02-01
This study was conducted to determine and compare the safety and effectiveness of two
neuromuscular blockers (rocuronium and vecuronium) at various doses in adults who are
undergoing general elective surgery with sevoflurane anesthesia.
Study participants received an intubating dose of a neuromuscular blocker (to enable
insertion of a tube through the nose or mouth into the trachea to provide artificial
ventilation). The intubating dose was followed by repeated bolus maintenance doses as needed,
to maintain muscle relaxation. The time it takes to reach maximal effect of the neuromuscular
blocker (onset time) after the intubating dose was measured and compared as the primary
outcome.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.